Literature DB >> 9117546

Motor neurone disease-inclusion dementia.

M Jackson1, G Lennox, J Lowe.   

Abstract

We describe nine patients, five women and four men (age at death 58-83 years), who developed isolated progressive frontotemporal dementia over 4 to 12 years. These cases represent nine of the 385 (2.3%) cases from a series of autopsy cases of dementia in a large teaching hospital. One had a mother with a history of frontotemporal dementia and marked frontal lobe atrophy. Another had multiple affected family members with frontotemporal dementia, motor neurone disease or both. None of the nine had clinical evidence of either an upper or lower motor neurone disorder. In each case neuropathological examination revealed cortical pathology identical to that described previously as typical of dementia associated with motor neurone disease. There was variable macroscopic atrophy and neuronal loss in the frontal and temporal lobes. All cases had cortical microvacuolation, in seven limited to cortical layer II, and transcortical in two. There was variable cortical and subcortical gliosis. Intraneuronal ubiquitin-immunoreactive inclusions, characteristic of the extra-motor involvement of motor neurone disease, were found in the hippocampal dentate granule cells and residual neurones in layer II of the frontotemporal cortex of all cases. Similar inclusions were also seen in the nucleus ambiguus of three cases. The hypoglossal nuclei showed no neuronal loss, gliosis or ubiquitin-immunoreactive inclusions. Ubiquitin-immunoreactive dystrophic neurites were detected within affected cortex, being most conspicuous in layer II in areas containing microvacuolation. Dystrophic neurites were not detected in subcortical structures. Spinal cords were unavailable for examination because of limited autopsy consent. The finding of intraneuronal ubiquitin-immunoreactive inclusions characteristic of motor neurone disease in patients with frontotemporal dementia, without clinical or pathological evidence of motor system degeneration, extends the clinical spectrum of diseases associated with such inclusions. We propose the term motor neurone disease-inclusion dementia (MNDID) for these cases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9117546     DOI: 10.1006/neur.1996.0046

Source DB:  PubMed          Journal:  Neurodegeneration        ISSN: 1055-8330


  19 in total

Review 1.  Advances in understanding the molecular basis of frontotemporal dementia.

Authors:  Rosa Rademakers; Manuela Neumann; Ian R Mackenzie
Journal:  Nat Rev Neurol       Date:  2012-06-26       Impact factor: 42.937

Review 2.  Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.

Authors:  Shahram Saberi; Jennifer E Stauffer; Derek J Schulte; John Ravits
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

3.  Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies.

Authors:  Deepak M Sampathu; Manuela Neumann; Linda K Kwong; Thomas T Chou; Matthew Micsenyi; Adam Truax; Jennifer Bruce; Murray Grossman; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

Review 4.  Frontotemporal dementia.

Authors:  Erik D Roberson
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

5.  Magnetization transfer imaging demonstrates a distributed pattern of microstructural changes of the cerebral cortex in amyotrophic lateral sclerosis.

Authors:  M Cosottini; I Pesaresi; S Piazza; S Diciotti; G Belmonte; M Battaglini; A Ginestroni; G Siciliano; N De Stefano; M Mascalchi
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-24       Impact factor: 3.825

6.  Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report.

Authors:  Maria Luisa Gorno-Tempini; Ryan C Murray; Katherine P Rankin; Michael W Weiner; Bruce L Miller
Journal:  Neurocase       Date:  2004-12       Impact factor: 0.881

Review 7.  The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Ian R A Mackenzie; Rosa Rademakers
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

8.  A case study of an emerging visual artist with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Anli Liu; Kelly Werner; Subhojit Roy; John Q Trojanowski; Ursula Morgan-Kane; Bruce L Miller; Katherine P Rankin
Journal:  Neurocase       Date:  2009-06       Impact factor: 0.881

Review 9.  The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments.

Authors:  Ian R A Mackenzie; Rosa Rademakers
Journal:  Neurogenetics       Date:  2007-09-06       Impact factor: 2.660

10.  A new subtype of frontotemporal lobar degeneration with FUS pathology.

Authors:  Manuela Neumann; Rosa Rademakers; Sigrun Roeber; Matt Baker; Hans A Kretzschmar; Ian R A Mackenzie
Journal:  Brain       Date:  2009-08-11       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.